(Q38113819)

29 August 2017

title

Possible role of PGRMC1 in breast cancer development (English)

1 reference

29 August 2017

H Neubauer

1

1 reference

29 August 2017

Q Ma

2

1 reference

29 August 2017

J Zhou

3

1 reference

29 August 2017

Q Yu

4

1 reference

29 August 2017

X Ruan

5

1 reference

29 August 2017

H Seeger

6

1 reference

29 August 2017

T Fehm

7

1 reference

29 August 2017

A O Mueck

8

1 reference

29 August 2017

publication date

12 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

16

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

509-513

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progesterone receptor membrane component 1: an integrative review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Non-genomic steroid actions in human spermatozoa. "Persistent tickling from a laden environment".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Expression and regulation of progestin membrane receptors in the rat corpus luteum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Hypoxia and breast cancer: prognostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Hpr6.6 protein mediates cell death from oxidative damage in MCF‐7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Ubiquitination of 3-hydroxy-3-methylglutaryl-CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

Progesterone receptor membrane component 1 (PGRMC1) gene expression in corpus luteum during the estrous cycle in cows

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.800038

10.3109/13697137.2013.800038

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference